adriana platona biography

• Forgot password?

Department of Health confirms 'TAA' leadership

A permanent appointment as first assistant secretary of the Department of Health's Technology, Assessment and Access division.

Adriana Platona PSM, who has been serving in the role since May, has been confirmed in the position by Department of Health secretary Glenys Beauchamp.

Ms Platona returned from the TGA to act in the role when incumbent Penny Shakespeare was appointed to act as deputy secretary for Health Financing following the departure of Mark Cormack.

Ms Shakespeare has subsequently been confirmed in the role. 

Health Financing includes Technology, Assessment and Access, Medical Benefits and Provider Benefits Integrity.

Its divisions are responsible for tens of billions in government expenditure through major public health programs like the PBS and Medicare. Its policy areas also include private health insurance and incorporate the Prostheses List Advisory Committee.

Ms Platona was head of the  TGA's medical devices and product quality division having previously served as  assistant secretary of the Department of Health's pharmaceutical evaluation area.

She was highly respected across the sector and was recognised with a Public Service Medal for her role in the reimbursement of the new generation direct-acting antivirals for hepatitis C.

Stay Informed

Sign up to receive email updates from HealthDispatch.

New Stories

Dr rachel david: let’s get real about what’s ailing private hospitals, hbf to adjust branch network as digital interactions with members increase, insurers say medicare has served australia well but it’s time for a mid-life health check, health funds call for ‘surprise billing law’ in response to higher costs for procedures, science & technology australia slams budget 'raid' on support for commercialisation, budget update confirms the creation of genomics australia delayed until mid-2025, medibank releases its top private health insurance claims for 2023.

• Forgot password?

Queen's birthday honours for CSL chair and leading health policy-maker

CSL has paid tribute to Professor John Shine after the company's chair was made a Companion in the General Division (AC) in the Queen's birthday honours list.

Professor Shine was recognised  for "eminent service to medical research, particularly in the area of biopharmaceuticals and molecular biology, to higher education as an academic, to professional medical organisations, and as a supporter of the advancement of innovation in science."

"CSL congratulates Professor John Shine on being awarded the Companion of the Order of Australia for his service to medical research. John’s work has made an important contribution to the field of molecular biology and our understanding of gene expression," said a spokesperson for the company.

"The AC is well deserved recognition of the value of John’s work to the millions of patients who have benefited from his research. More broadly, the award acknowledges the significant contribution of Australian science to the field of medical research."

A leading health policy maker, Adriana Platona, was also recognised with a Public Service Medal.

Ms Platona, who is the c urrent head of the TGA's medical devices and product quality division, received the award for  her role negotiating the reimbursement of the new generation cures for hepatitis C. She was previously assistant secretary of the Department of Health's pharmaceutical evaluation area.

According to the citation, "Medicines for Hepatitis C are extremely costly and Ms Platona negotiated with international pharmaceutical companies to set an agreed price the Australian Government would pay for the drugs that was best value for the Government and the Australian public.

"The success of the PBS listing relied on her intellectual rigour and highly skilful navigation of a range of complex issues around the listing. She applied her expertise, experience and understanding of the pharmaceutical industry to these negotiations to ensure maximum value to the Australian Government and patients. Ms Platona pushed ahead with protracted negotiations in an uncompromising fashion with tact and diplomacy."

New Stories

Federal 2024-25 budget wrap up for biotech, anteris technologies welcomes first procedures using its duravr, pyc therapeutics updates on dosing study of eye disease study, digital health research sector welcomes budget initiatives, chimeric announces re-opening of phase 1b study of chm core-nk, tga seeks views on proposed medical device reform changes, pyc therapeutics plans to progress candidate to human clinical trials.

• Member Login

Independent Chair of Health Technology Assessment (HTA) Review will drive major reform of Australia’s health system

27 October 2022: Medicines Australia welcomes the appointment of Adjunct Professor Debora Picone AO as independent Chair of the Health Technology Assessment (HTA) Review Reference Committee, announced today by the Minister for Health and Aged Care, the Hon. Mark Butler MP and the extension of the HTA Review deadline until 31 December 2023.

Chair of Medicines Australia, Dr Anna Lavelle, said Adjunct Professor Picone AO will lead major reforms that will speed up access to innovative medicines for all Australians.

“The HTA Review will ensure Australia’s health system keeps pace with advancements in medical technologies and deliver faster access to new medicines for patients,” Dr Lavelle said.

“Reform of Australia’s HTA system is well overdue. We must reduce the time it takes for Australian patients to access innovative medicines, treatments and health technologies.

“Our health system must be modernised with a clear focus on patient needs and listening to patient perspectives.

“Adjunct Professor Picone AO and the HTA Review Reference Committee will be taking part in the first major review and reform of the HTA system in 30 years. It is a pivotal opportunity to improve this crucial process in accessing innovative medicines.

“The Board of Medicines Australia thanks Minister Butler for his consultative approach to the appointment of the Chair which signals the Government’s desire to work collaboratively with stakeholders on reforming HTA,” Dr Lavelle said.

CEO of Medicines Australia, Elizabeth de Somer, said the COVID-19 pandemic has shown the importance of rapid access to innovative medicines, vaccines and therapies.

“The much-anticipated reform of our HTA system can bring about change so all Australians have fast access not just to COVID-19 vaccines and treatments, but all innovative medicines,” Ms de Somer said.

“Adjunct Professor Picone’s experience as CEO of the Australian Commission in Safety and Quality of Healthcare and other health-related committees demonstrates her appetite for change and ability to work with stakeholders to seize opportunities that will improve health outcomes of all Australians.

“The Chair has the important role of maintaining autonomy while working in partnership with Government, clinicians, industry and patients to improve Australia’s health system and meet future patient needs. Debora Picone is well known as an independent thinker, with a strong pragmatic and patient centred approach, which will be critical in driving true reform.

“Fast access to innovative medicines is fundamental to a healthy and productive population. The outcomes from the HTA Review must place patients and the community at the centre of Australia’s reimbursement system, so  the real benefits of new medicines, treatments and vaccines are understood and valued,” Ms de Somer said.

The other Committee members are Mr John Young (Medicines Australia); Professor Andrew Roberts AM (Clinical/Scientific Expert); Professor Andrew Wilson (Chair of the Pharmaceutical Benefits Advisory Committee); Dr Dawn Casey PSM (National Aboriginal Community Controlled Health Organisation – NACCHO); Ms Ann Single (Patient Voice Initiative); and Ms Adriana Platona PSM (Government Representative).

Medicines Australia has collaborated with members and stakeholders to develop a draft set of recommended terms of reference for the HTA Review Reference Committee to consider in their development of the scope of the Review.

For further information or media interviews, please contact: Chrystianna Moran – 0424 995 118 /  [email protected] Margaret Cresswell – 0410 456 293 /  [email protected]

ABOUT ADJUNCT PROFESSOR DEBORA PICONE AO (just appointed independent Chair of the HTA Review Reference Committee)

Adjunct Professor Debora Picone AO has been CEO of the Australian Commission on Safety and Quality in Health Care since 2012. She has had extensive experience and leadership positions in healthcare services in clinical, academic, hospital and area health. Adjunct Professor Picone was the Director-General of NSW Health from 2007 to 2011 and is a former nurse, giving her experiences and insights into the challenges that patients face when accessing cutting edge health care, medicines and technologies.

ABOUT JOHN YOUNG (industry representative on the HTA Review Reference Committee)

John Young served as Group President and Senior Advisor to the Pfizer Chief Executive Officer prior to his retirement from Pfizer in mid-2022. A scientist by training, John has almost 35 years of experience with Pfizer and has held several senior positions across the organisation. John was Managing Director of Pfizer Australia Pty Ltd between 2004-2007 and was Chair of the Medicines Australia Board from 2006-2007. He also played an integral role in the collaborations that led to the successful development and delivery of the Pfizer-BioNTech COVID-19 vaccine.

Media release sign up

Sign up and get the latest Media Releases and event information.

• Phone This field is for validation purposes and should be left unchanged.

Australian Government Department of Health and Aged Care

HTA Review Reference Committee

The HTA Review Reference Committee is responsible for overseeing the Health Technology Assessment (HTA) Policy and Methods Review.

The HTA Review Reference Committee will oversee the Health Technology Assessment (HTA) Policy and Methods Review.

The HTA Review Reference Committee will:

• agree the terms of reference for the HTA Review
• agree the expert in HTA to support the HTA Review
• oversee public consultations and considering submissions to the HTA Review
• oversee the analysis undertaken by the expert in HTA
• prepare a final review report and recommendations.

Meeting agendas

The committee held meetings as needed to meet the 31 December 2023 review deadline.

HTA Review Reference Committee – Meeting agendas

Communiques.

HTA Review Reference Committee – Communiques

Other documents.

Health Technology Assessment Review – Probity Plan

Health Technology Assessment Policy and Methods Review Reference Committee Principles – Confidentiality and Transparency

Health Technology Assessment Policy and Methods Review Reference Committee Principles – Conference Attendance

HTA Review Secretariat

• Health technologies and digital health
• Health Technology Assessment Policy and Methods Review

• University of Pennsylvania
• School of Arts and Sciences
• Penn Calendar

Search form

Department of anthropology.

Adriana Petryna

University Museum Room 334

Adriana Petryna is Professor in Anthropology and directs the  MD-PhD program in Anthropology  at the University of Pennsylvania. In her ethnographic studies in Eastern Europe and the United States, she probes the socio-political natures of science, how populations are enrolled in experimental knowledge-production, and what becomes of citizenship and ethics in that process. She is the author of the award-winning books, including  Life Exposed: Biological Citizens after Chernobyl  and  When Experiments Travel: Clinical Trials and the Global Search for Human Subjects , and is co-editor of  Global Pharmaceuticals: Ethics, Markets, Practices  and  When People Come First: Critical Studies in Global Health . Petryna’s concepts of biological citizenship, ethical variability, and experimentality have advanced the critical social scientific study of environmental disasters, biomedical research and equity, and global health. Her new book,  Horizon Work: At the Edges of Knowledge in an Age of Runaway Climate Change ,  examines the climate crisis through the lens of “horizoning,” a mode of reckoning that considers unnatural disasters against horizons of expectation in which people and societies can still act. She focuses on experiments probing planetary points of no return as well as the stories of wildland firefighters, for whom trust in patterns becomes an occupational hazard. A Guggenheim Fellow , Petryna’s research has been supported by the National Science Foundation, the National Endowment for the Humanities, the Wenner-Gren Foundation, the Social Science Research Council, and the School for Advanced Research. She was a Member of the School of Social Science at the Institute for Advanced Study and a Faculty Fellow at Princeton University’s Center for Human Values. At Penn, Dr. Petryna also directs the undergraduate concentration in Medical Anthropology and Global Health .

Ph.D. Anthropology, University of California, Berkeley; M.A. Anthropology & M.Arch., University of California, Berkeley; B.S. Architecture, University of Michigan, Ann Arbor.

Selected Publications

Life Exposed: Biological Citizens after Chernobyl (Princeton University Press, 2002. Tenth Anniversary paperback edition with a New Introduction, 2013).

• Sharon Stephens First Book Prize, American Ethnological Society, American Anthropological Association, 2003 
• New Millennium Book Award, Society for Medical Anthropology, 2006 
• The Wellcome Medal for Anthropology as Applied to Medical Problems, Royal Anthropological Institute, 2014

Global Pharmaceuticals: Ethics, Markets, Practices , Edited by Adriana Petryna, Andrew Lakoff, Arthur Kleinman (Duke University Press, 2006).

When Experiments Travel: Clinical Trials And The Global Search For Human Subject (Princeton University Press, 2009).

• Diana Forsythe Prize, Honorable Mention, Society for the Anthropology of Work and the Committee for the Anthropology of Science, Technology, and Computing, American Anthropological Association, 2014

When People Come First: Critical Studies in Global Health , Edited by João Biehl & Adriana Petryna (Princeton University Press, 2013).  

• See the When People Come First website here .
• Read a review of When People Come First here .

Horizon Work: At the Edges of Knowledge in an Age of Runaway Climate Change (Princeton University Press, 2022).

• Diana Forsythe Prize , Society for the Anthropology of Work and the Committee for the Anthropology of Science, Technology, and Computing, American Anthropological Association, 2022.

Selected Essays

“De-occupation as Planetary Politics: On the Russian War in Ukraine.” American Ethnologist, Jan 27, 2023:1–9.

“ Autocracy and Planetary Harm .” October 28, 2022.  piauí / Folha de S.Paulo

“ Wildfires have changed, firefighting hasn’t .” July 10, 2022.  LA Times .

" What Russia Is Stirring Up at Chernobyl ." March 2, 2022. The Atlantic .

" The COVID Horizon : An Introduction." co-authored with Sara Rendell. Medicine Anthropology Theory 8(1), 1-7. April 23, 2021.

" Wildfires at the Edges of Science : Horizoning Work amid Runaway Change," 2018, Cultural Anthropology , Vol. 33, Issue 4, pp. 570-595.

" Searches for Livability : An Interview with Adriana Petryna," Cultural Anthropology . Feb 6, 2019. Interview by Pablo Seward Delaporte and Sonia A. P. Grant (supplement to research article "Wildfires at the Edges of Science: Horizoning Work amid Runaway Change," published in Cultural Anthropology in November 2018).

" On the Nature of Catastrophic Forms " with Paul W. Mitchell. BioSocieties . 2017. 2(3):343-366.

“ What is a Horizon? Navigating Thresholds in Climate Change Uncertainty,” Modes of Uncertainty: Anthropological Cases . P. Rabinow and L. Samimian-Darash, eds. Chicago University Press. 2015:147-164.

" Risks of Citizenship and Fault Lines of Survival " with K. Follis. Annual Review of Anthropology . 2015. 44:401-417.

“ How Did They Survive? ” New Introduction for Tenth Anniversary paperback edition of Life Exposed: Biological Citizens after Chernobyl . Princeton: Princeton University Press, 2013:1-19.

" Peopling Global Health " (with J. Biehl), Revista Saúde e Sociedade . 2014. 23 (2):376-389.

" The Right of Recovery ,"  Current Anthropology (based on Wenner-Gren Symposium, The Anthropology of Potentiality). 2013, 54(S7):S67-S76.

" The Origins of Extinction "  Limn , 2013:50-53.

“ Paradigms of Expected Failure ,” Dialectical Anthropology , 2010, 34:57–65.

" Ethical Variability : Drug Development and the Globalization of Clinical Trials.” American Ethnologist , 2005, 32(2):183-197. 

" Clinical Trials Offshored : On Private Sector Science and Public Health."  BioSocieties , 2007, 2:21-40.

" Biological Citizenship : The Science and Politics of Chernobyl-Exposed Populations."  Osiris , 2004, 19: 250-265.

" Chernobyl's Survivors : Paralyzed by Fatalism or Overlooked by Science?"  Bulletin of the Atomic Scientists . March/April 2011 67: 30-37.

“ Nuclear Payouts : Knowledge and Compensation in the Chernobyl Aftermath,” Anthropology Now , 2009, 1(2):30-40.

Read an interview with Dr. Adriana Petryna about When Experiments Travel

Read an interview with Dr. Adriana Petryna about Chernobyl and the Fukushima nuclear power plant accident

Read about " Philly as lab, classroom, and collaborator "

Read about the MD-PhD Program in Anthropology

Recently Taught Courses

Undergraduate:

Introduction to Medical Anthropology; Cultures of Science and Technology; Local Biologies: Interactions between Biological and Cultural Systems; Pharmaceuticals and Global Health; Global Health: Anthropological Perspectives; Anthropology of the Environment Graduate: Planetary Health; Advanced Topics in Science and Technology; Theory in Contemporary Ethnography; Cultures of Medicine: Care at the Limits of Life and Death; Rethinking Healing; Contemporary Approaches to the Study of Culture and Society; Formations of the Public

Courses Taught

Courses Taught:

ANTH2060 Cultures of Science and Technology

ANTH1238 Introduction to Medical Anthropology

ANTH5540 Truth, Politics, Ethics: Anthropological Cases

ANTH6010 Contemporary Approaches to the Study of Culture and Society

ANTH2730 Global Health: Anthropological Perspectives

ANTH3429 Anthropology of the Environment

Affiliations

Anthropology Department Faculty; Faculty Mentor and Associate, Penn Medical Scientist Training Program (MSTP); Faculty Associate, History and Sociology of Science; Faculty Advisor, Penn Program in Environmental Humanities ; Affiliated Faculty, Russian and East European Studies; Director, MD-PhD Program Anthropology.

Geographical Area

Research interests, faculty status.

Adriana Lima

• Born June 12 , 1981 · Salvador, Bahia, Brazil
• Birth name Adriana Francesca Lima
• Height 5′ 10″ (1.78 m)
• Adriana Lima is a Brazilian supermodel, actress and businesswoman. From the young age of fifteen, Adriana's portfolio quickly skyrocketed making her one of the most successful models of all time. A global fashion icon, best known as a Victoria's Secret from 1999 to 2018, the longest-running model and named "the most valuable Victoria's Secret Angel" in 2017, Adriana has also branched into film and television acting. Adriana's 2009 Victoria's Secret Super Bowl commercial reached 103.7 million viewers! It was declared "The Most Watched Commercial in the History of Television" by Nielsen. Her modeling career started after winning Ford's "Supermodel of Brazil" competition and finishing at the second place in the "Supermodel of The world." Thereafter, Elite Model Management signed Adriana Lima as a model. During her time at Victoria's Secret, Adriana opened the show on 5 distinct occasions in 2003, 2007, 2008, 2010 and 2012. Adriana is one of only 2 angels to have worn the Fantasy bra 3 times. She also participated to the "Angels Across America" tour, a nationwide promotion campaign for Victoria's Secret with 4 other Angels in 2004. Her last show was in 2018 after participating in 18 catwalks for Victoria's Secret. She also walked well-known designers runway shows like Versace, Jason Wu, Giorgio Armani, Vera Wang, Louis Vuitton, Prada, Christian Dior, Alexandre Herchcovitch, and Anna Sui. Her status ensured her a spot on the cover some of the most notable international magazines such as Vogue, Harper's Bazaar, ELLE, Grazia, GQ, Numero, Playboy, Cosmopolitan, Esquire across many countries including the USA, Spain, United Kingdom, France, Brazil, Italy, Portugal, Mexico, Korea, Japan, Turkey, Germany, Russia, South Africa, Thailand, Sweden, Czech Republic... Ethnically, Adriana is Afro-Brazilian of Portuguese, Swiss, Native Brazilian, Japanese, and West Indian ancestry. - IMDb Mini Biography By: Laurent Boye of Jazo PR
• Spouse Marko Jaric (February 14, 2009 - March 14, 2016) (divorced, 2 children)
• Children Sienna Lima Jaric Valentina Lima Jaric Cyan Lima Lemmers
• Parents Nelson Torres Maria da Graça Lima
• Mole on her chin
• Tall stature
• Striking aquamarine eyes
• Gave birth to her first child at age 28, daughter Valentina Lima Jaric on November 15, 2009. Child's father is her now ex-husband, Marko Jaric.
• Ethnicity is Native-Brazilian, African-Brazilian, Portuguese, Swiss, Japanese and Caribbean. Adriana has stated that she considers herself Afro-Brazilian first.
• She's the second best paid Brazilian model. The first is Gisele Bündchen .
• Her father, Nelson Torres, abandoned his wife and Adriana when she was 6 months old.
• Is the longest-running Angel in the history of Victoria's Secret, first posing for them in 1999 at age 18.
• Modeling is a tough job, your co-workers are your rivals, it really puts a damper on your perspective of other girls.
• Fashion is about good energy. It's about feelings. That's what I have to give the people, good energy and good feelings.
• I want to be a child doctor. A pediatry...how do you call it, pediatrician? Do I like kids? No, not really.
• Sex is for after marriage. They [men] have to respect that this is my choice. If there's no respect, that means they don't want me.
• Boxing is my exercise, my passion.

Contribute to this page

• Learn more about contributing

More from this person

• View agent, publicist, legal and company contact details on IMDbPro

More to explore

Recently viewed

• Forgot password?

Official extends time at TGA

Another change inside the Department of Health's Pharmaceutical Benefits Division, with Karen Binnekamp taking on the role of acting Assistant Secretary of the all-important Pharmaceutical Evaluation Branch.

Ms Binnekamp has served in a range of roles in pharmaceutical policy, including as secretary to the abolished Pharmaceutical Benefits Pricing Authority, and succeeds Dianna Prosser, who was acting in the role in place of Adriana Platona. 

Ms Platona has been serving in a senior position at the TGA, as acting First Assistant Secretary, Medical Devices and Product Quality Division.

While her move was temporary, with a return expected recently, Ms Platona's tenure at the TGA has been extended and is now expected to last into next year.

While her successors are highly respected, Ms Platona's absence has triggered significant concern, particularly coming on the back of other recent departures.

The Pharmaceutical Evaluation Branch plays the central role in managing the listing process for new medicines.

Latest Video

Just to be clear, the comment was completely tongue-in-cheek

Can we just have an honest conversation about budget and reform, astrazeneca welcomes action on co-pays but calls for more on access, new stories, health department makes a major change inside critical division, baxter launches the mission and logo of new kidney care company, nz prime minister says, 'we are recognising that we have a problem'.

Your guide to the structures , organisations and key people in the Australian Government

• Adriana Platona

Ms. Adriana Platona

Substantive roles, first assistant secretary, quick feedback.

Let us know what you think of this page. Your ideas and feedback are encouraged and will be used to help us prioritise design fixes and new features.